Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

[<sup>18</sup>F]FDG PET/CT Radiomics for Predicting Pathological Risk Subtypes of Thymic Epithelial Tumors: A Bicentric Study.

Cancers·2026
Same author

Development of a Radiologic Nomogram to Predict Invasiveness in Pulmonary Pure Ground-Glass Opacities: Analysis of the GORDON Cohort.

Cancers·2026
Same author

Predictors of Recurrence After Surgery in Patients with Stage I Non-Small Cell Lung Cancer.

Cancers·2026
Same author

Molecular Landscape of Resected Thymomas: Insights from Mutational Profiling.

Diagnostics (Basel, Switzerland)·2026
Same author

Bridging the sensory gap: intraoperative lung ultrasound for deep pulmonary nodule localization in totally endoscopic robotic thoracic surgery.

Updates in surgery·2026
Same author

From Awake to Minimalist Spontaneous Ventilation Thoracoscopic Mediastinum Surgery: How Far Are We?

Journal of clinical medicine·2025

相关实验视频

Updated: Jan 18, 2026

A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants
10:44

A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants

Published on: August 9, 2019

7.6K

在手术切除的胸腺瘤中,编程死亡连接体1表达.

Luca Frasca1,2, Antonio Sarubbi1, Filippo Longo1

  • 1Department of Thoracic Surgery, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro Del Portillo 200, 00128, Rome, Italy.

Updates in surgery
|May 25, 2025
PubMed
概括

胸腺瘤中高编程死亡配体1 (PD-L1) 表达与复发风险增加有关. 这一发现表明PD-L1可能作为攻击性胸腺瘤亚型的预后生物标志物.

关键词:
在PD-L1中.复发情况 复发情况胸膜切除术 (thymectomy) 是一种切除术.胸膜上皮瘤 胸膜上皮瘤胸腺瘤是什么意思 胸腺瘤是什么意思

更多相关视频

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

18.1K
Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
09:06

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

1.9K

相关实验视频

Last Updated: Jan 18, 2026

A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants
10:44

A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants

Published on: August 9, 2019

7.6K
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

18.1K
Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
09:06

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

1.9K

科学领域:

  • 在瘤学瘤学.
  • 免疫学 免疫学 免疫学
  • 病理学 病理学 病理学

背景情况:

  • 胸腺瘤是常见的前中瘤,对于晚期的治疗选择有限.
  • 胸腺瘤的分子特征尚未得到充分理解.
  • 研究生物标志物对于改善患者的治疗结果至关重要.

研究的目的:

  • 评估被切除的胸腺瘤中编程死亡配体1 (PD-L1) 的表达.
  • 确定PD-L1表达与胸腺瘤复发风险之间的关系.
  • 探索PD-L1作为一个潜在的预后生物标志物在胸腺瘤.

主要方法:

  • 针对胸腺瘤进行完整胸膜切除术的患者的回顾性分析.
  • 使用Ventana PD-L1测定法测量PD-L1表达的免疫组织化学 (<50%低,≥50%高).
  • 卡普兰-梅尔和考克斯回归分析以将PD-L1表达与无病生存率相关联.

主要成果:

  • 高PD-L1表达 (≥50%) 在46.2%的患者中被发现.
  • 提升的PD-L1表达显著与攻击性胸腺瘤组织型 (B2/B3) 相相关.
  • 高PD-L1表达与减少无病存活率和更糟糕的预后 (HR 5.4,p=0.028) 相关,以及组织学和Masaoka-Koga阶段.

结论:

  • 提升PD-L1表达,特别是在侵略性胸腺瘤中,表明其作为预后生物标志物的潜力.
  • 这些结果凸显了对治疗胸腺瘤的免疫疗法的进一步研究的需要.
  • PD-L1 状态可以指导胸腺瘤患者的治疗策略.